An Observational Study to Evaluate Effectiveness and Safety of Amosartan Q Tablet
연구 개요
This study was to evaluate the therapeutic effect and safety of amosartan Q tablet administration in adult patients with hypertension and dyslipidemia. During the routine medical visit, Amosartan Q tablets were administered to patients in need of blood pressure/LDL-C control according to the investigator's judgment. In this study, effectiveness and safety information of treatment of Amosartan Q tablets was followed for 6 months (up to 12 months), and observation of the target patients was terminated after collecting relevant data. As this study was a non-interventional observational study, all patients received prescriptions according to the routine treatment procedure, and there were no visits or procedures required according to the observational study protocol.
- 스폰서
- 리드: 한미약품
- 적응증
- Hypertension, Dyslipidemia
- 중재
- Amosartan Q tablet
- 목표 등록
- 5,400명
- 시작일
- 2018-04-17
- 완료(예정)
- 2021-07-20
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.